跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,390 条关于
“858 Therapeutics”
全部
17,390
临床试验
3,956
药物
3,415
机构
1,127
资讯
8,892
去年
858 Therapeutics Secures $50 Million in Series B Funding to Advance PARG Inhibitor ETX-19477
8个月前
858 Therapeutics Receives FDA Fast Track Designation for PARG Inhibitor ETX-19477 in BRCA-Mutated Ovarian Cancer
3个月前
858 Therapeutics' PARG Inhibitor ETX-19477 Shows 57% ORR in BRCA-Mutated Ovarian and Breast Cancer, Earns FDA Fast Track Designation
上个月
Amygdala Neurosciences Announces FDA Clearance of IND for ANS-858, a First-in-Class ALDH2 Inhibitor
去年
Bright Light Therapy Shows Promise in Treating Various Forms of Depression
2年前
Novel Strategies Emerge to Optimize Treatment in EGFR-Mutant NSCLC
2年前
Amivantamab Plus Lazertinib Significantly Improves PFS in High-Risk EGFR-Mutant NSCLC
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
去年
Resolution Therapeutics Secures $85 Million to Advance Macrophage Therapy for End-Stage Liver Disease
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
第 1 页,共 890 页
上一页
下一页